Free Trial

DocuSign, Inc. (NASDAQ:DOCU) Shares Acquired by Mitsubishi UFJ Asset Management Co. Ltd.

DocuSign logo with Computer and Technology background
Remove Ads

Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 10.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 149,797 shares of the company's stock after acquiring an additional 14,216 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.07% of DocuSign worth $13,513,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Korea Investment CORP boosted its stake in shares of DocuSign by 46.2% during the 4th quarter. Korea Investment CORP now owns 223,591 shares of the company's stock worth $20,110,000 after acquiring an additional 70,606 shares in the last quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund purchased a new position in DocuSign during the fourth quarter worth approximately $558,000. Meiji Yasuda Asset Management Co Ltd. grew its holdings in DocuSign by 64.7% in the fourth quarter. Meiji Yasuda Asset Management Co Ltd. now owns 16,873 shares of the company's stock valued at $1,518,000 after purchasing an additional 6,631 shares during the period. FineMark National Bank & Trust acquired a new stake in DocuSign in the fourth quarter valued at approximately $210,000. Finally, Corebridge Financial Inc. increased its position in shares of DocuSign by 5,847.3% in the fourth quarter. Corebridge Financial Inc. now owns 232,005 shares of the company's stock valued at $20,867,000 after buying an additional 228,104 shares in the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Insider Buying and Selling at DocuSign

In other DocuSign news, insider Robert Chatwani sold 15,706 shares of the firm's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $83.19, for a total transaction of $1,306,582.14. Following the transaction, the insider now owns 76,842 shares of the company's stock, valued at approximately $6,392,485.98. This trade represents a 16.97 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider James P. Shaughnessy sold 7,500 shares of the company's stock in a transaction that occurred on Tuesday, April 1st. The stock was sold at an average price of $81.31, for a total transaction of $609,825.00. Following the completion of the sale, the insider now directly owns 45,875 shares of the company's stock, valued at approximately $3,730,096.25. This represents a 14.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 57,851 shares of company stock worth $4,911,319. 1.66% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have issued reports on DOCU shares. UBS Group decreased their price objective on shares of DocuSign from $100.00 to $90.00 and set a "neutral" rating on the stock in a report on Friday, March 14th. Needham & Company LLC reaffirmed a "hold" rating on shares of DocuSign in a research report on Friday, March 14th. Hsbc Global Res upgraded DocuSign to a "moderate sell" rating in a research note on Friday, December 6th. Citigroup lifted their price target on DocuSign from $113.00 to $115.00 and gave the stock a "buy" rating in a report on Friday, March 14th. Finally, William Blair upgraded DocuSign from a "market perform" rating to an "outperform" rating in a research note on Monday, March 17th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $95.83.

Get Our Latest Analysis on DOCU

DocuSign Stock Performance

Shares of DocuSign stock traded down $5.16 during trading hours on Friday, reaching $72.21. The company's stock had a trading volume of 2,881,620 shares, compared to its average volume of 2,700,521. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The company's 50 day simple moving average is $86.02 and its 200 day simple moving average is $82.17. The stock has a market cap of $14.62 billion, a P/E ratio of 14.89, a price-to-earnings-growth ratio of 6.94 and a beta of 1.20.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.84 by $0.02. The firm had revenue of $776.25 million for the quarter, compared to analysts' expectations of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. DocuSign's revenue was up 9.0% on a year-over-year basis. During the same quarter last year, the company posted $0.76 earnings per share. On average, sell-side analysts predict that DocuSign, Inc. will post 1.17 earnings per share for the current fiscal year.

DocuSign Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Articles

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Should You Invest $1,000 in DocuSign Right Now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads